Information  X 
Enter a valid email address

Tiziana Life Sci PLC (TILS)

  Print      Mail a friend

Wednesday 12 September, 2018

Tiziana Life Sci PLC

PDMR dealings

RNS Number : 4766A
Tiziana Life Sciences PLC
12 September 2018
 

For immediate release 12 September 2018

 

Tiziana Life Sciences plc

(Incorporated in England and Wales with company number 09665181)

PDMR dealings

 

Tiziana Life Sciences plc (LSE: TILS) (the "Company") announces that on 10 September 2018, Panetta Partners Limited, an entity closely associated with Gabriele Cerrone, Executive Chairman, bought shares in the Company as follows:

The information set out below is provided in accordance with the requirements of Regulation 19(3) of the EU Market Abuse Regulation No 596/2014:

 

1.

Details  of PDMR / person closely associated

a)

Name

Gabriele Cerrone/Panetta Partners Limited

2.

Reason for the notification: On market acquisition

a)

Position / status

Executive Chairman

b)

Initial notification /amendment

Initial notification

3.

Details of the issuer

a)

Name

Tiziana Life Sciences plc

b)

LEI

213800CED47HI8PIOB36

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type  of transaction; (iii) each date; and (iv) each place where transactions have  been conducted

a)

Description of the financial instrument

Ordinary Shares of nominal value 3p each

b)

Identification code of the Financial Instrument

ISIN for Tiziana Life Sciences plc: GB00BKWNZY55

c)

Nature of the transaction

Acquisition of shares  

d)

Price(s) and volume(s)



Price: £1.05; Volume: 1,000

e)

Aggregated information

-     Aggregated volume

-     Price

 

1,000

£1,050

 

 

f)

Date of the transaction

10 September 2018

g)

Place of the transaction

XLON  

 

As a result of this transaction Mr Cerrone's interests in the shares of the Company increases from 64,179,170 (50.56%) to 64,180,170 (50.56%). Mr Cerrone's interests in the shares of the Company are based on a holding of 63,680,404 shares held by Planwise Limited and 499,766 shares held by Panetta Partners Limited. Mr Cerrone is considered beneficially interested in the holdings of Panetta Partners Limited and Planwise Limited.

For more information go to http://www.tizianalifesciences.com

 

Contacts:

 

Tiziana Life Sciences plc

Gabriele Cerrone, Chairman and founder

 

 

 

+44 (0)20 7493 2853

Cairn Financial Advisers LLP (Nominated adviser)

Liam Murray / Jo Turner

+44 (0)20 7213 0883

Stockdale Securities (Broker)

Antonio Bossi / Andy Crossley

 

+44 (0)20 7601 6100

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHSFWFWFFASEDU

a d v e r t i s e m e n t